RAJU MALLA: Open Payments
NPI 1477116176 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,802 in 98 payments from 18 companies in 2025. Trend: 2023 $2,800 · 2024 $653 · 2025 $1,802
Food & beverage: $1,707Education: $95
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 24 | $411 |
| ABBVIE INC. | 29 | $346 |
| Regeneron Healthcare Solutions, Inc. | 6 | $228 |
| Janssen Biotech, Inc. | 9 | $199 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $135 |
| Arcutis Biotherapeutics, Inc. | 3 | $107 |
| LEO Pharma Inc. | 3 | $66 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| UCB, Inc. | 2 | $57 |
| Blueprint Medicines Corporation | 1 | $35 |
Products named: COSENTYX, SKYRIZI, TREMFYA, DUPIXENT, Zoryve, ILUMYA, Sotyktu, Bimzelx.
Industry payments across NY — which companies pay providers there.
